Search results for "Cut"

showing 10 items of 5063 documents

Percutaneous Tibial Nerve Stimulation for Treatment of Idiopathic Faecal Incontinence: Mid-term Results from a Single Center

2016

Abstract Objective: Percutaneous tibial nerve stimulation is a recent and minimally invasive treatment for faecal incontinence (FI). The aim of this study is to evaluate the mid-term results in patients with idiopathic faecal incontinence (IFI). Methods: Fifty one patients (42 female and 9 male) were prospectively recruited. Patients were treated twice a week for 6 weeks as per study protocol. We have assessed the degree of fecal incontinence using the Cleveland Clinic faecal incontinence (CCF-FI) score at baseline, at 6 weeks, at 6 months and at 1 year. Also the anorectal manometric data (mean resting pressure (MRP), squeeze pressure (SP) and, rectal sensation) at baseline, at 6 weeks and …

medicine.medical_specialtyIdiopathic faecal incontinencebusiness.industryAnorectal manometryIdiopathic faecal incontinence; Posterior tibial nerve stimulation; TreatmentMid term resultsIdiopathic faecal incontinenceStimulationSingle CenterSurgeryTreatment03 medical and health sciencesSettore MED/18 - Chirurgia Generale0302 clinical medicineInterquartile range030220 oncology & carcinogenesismedicineFecal incontinence030211 gastroenterology & hepatologymedicine.symptomPercutaneous tibial nerve stimulationbusinessPosterior tibial nerve stimulation
researchProduct

Lindane-induced changes in carbohydrate metabolism in Anguilla anguilla

1992

Abstract 1. Anguilla anguilla (L.) was exposed to a sublethal concentration of 0.167 ppm (0.25 of the 96-hr lc 50 ) of lindane for 6, 12, 24, 48, 72 and 96 hr. 2. Changes in glycogen, glucose, pyruvate and lactate contents of liver and muscle after lindane exposure, were studied. 3. Muscle and liver glycogen levels decreased significantly during the exposure time. Muscle glucose values increased but on the other hand we found a decrease in those of liver. 4. Muscle and liver pyruvate content increased as did lactate levels in both tissues. 5. The observed effects of lindane on carbohydrate metabolism in fish are discussed in relation to acute stress syndrome.

medicine.medical_specialtyImmunologyBiologyCarbohydrate metabolismchemistry.chemical_compoundInternal medicinePyruvic AcidmedicineAnimalsLactic AcidAcute stressPyruvatesPharmacologyGlycogenMusclesMetabolismCarbohydrateAnguillaGlucoseEndocrinologyLiverchemistryLactatesCarbohydrate MetabolismFish <Actinopterygii>LindaneGlycogenHexachlorocyclohexaneComparative Biochemistry and Physiology Part C: Comparative Pharmacology
researchProduct

Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications.

2002

Abstract Severe acute pancreatitis causes a high incidence of mortality due to the systemic inflammatory response syndrome leading to multiple organ failure. At present, there is no treatment against severe acute pancreatitis, other than supportive critical care. The relationship between pancreatic injury and the uncontrolled systemic response is not completely understood. Nevertheless, experimental and clinical evidences have shown that pro-inflammatory cytokines and oxidative stress are critically involved in the development of local and systemic complications associated with severe acute pancreatitis. Serum levels of pro-inflammatory cytokines, such as TNF-alpha and IL-1beta, increase du…

medicine.medical_specialtyImmunologyInflammationmedicine.disease_causePentoxifyllinechemistry.chemical_compoundInternal medicinemedicineImmunology and AllergyHumansXanthine oxidasePharmacologyInflammationbusiness.industryPneumoniamedicine.diseaseSystemic inflammatory response syndromeOxidative StressEndocrinologymedicine.anatomical_structurechemistryPancreatitisImmunologyAcute DiseaseAcute pancreatitisCytokinesPancreatic injurymedicine.symptombusinessPancreasOxidative stressmedicine.drugCurrent drug targets. Inflammation and allergy
researchProduct

Clinical evaluation and treatment of acute asthma exacerbations in children

2009

This update on treatment of asthma exacerbations in children is the result of an Italian Pediatric Society Task-force, made up of a panel of experts working in 2007–2008. The aim is to give clear indications on the use of the drugs most employed in children, grading the quality of evidence and the strength of recommendations. Suggestions on their limits due to unlicensed and off-label use are reported. The level of evidence and the strength of recommendations for different therapeutic approaches demonstrate that frequently the use of drugs in children is extrapolated from the experience in adults and that more studies are required to endorse the correct use of different drugs in asthmatic …

medicine.medical_specialtyImmunologyMEDLINESeverity of Illness Index; Acute Disease; Evidence-Based Medicine; Off-Label Use; Hospitalization; Humans; Treatment Outcome; Practice Guidelines as Topic; Asthma; Anti-Asthmatic Agents; Child; Child PreschoolOff-label useSeverity of Illness IndexSeverity of illnessHumansAnti-Asthmatic AgentImmunology and AllergyMedicineAnti-Asthmatic AgentsChildIntensive care medicineGrading (education)PharmacologyEvidence-Based MedicineAsthma exacerbationsbusiness.industryOff-Label UseEvidence-based medicineAsthmaHospitalizationQuality of evidenceacute asthma; children; emergency treatmentTreatment OutcomeSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAChild PreschoolAcute DiseasePractice Guidelines as Topicacute asthma exacerbations in childrenbusinessacute asthma exacerbations in children.Clinical evaluationHuman
researchProduct

The skin in autoimmune diseases-Unmet needs.

2016

Treatment of skin manifestations in systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and dermatomyositis (DM) is based on the results of only few randomized controlled trials. The first-line treatment for disfiguring and widespread cutaneous involvement in SLE is antimalarials, but some patients are therapy resistant. Recently, the monoclonal antibody belimumab was approved for SLE as an adjunct therapy for patients with autoantibody-positive disease who despite standard therapy show high disease activity, intolerance of other treatments, or an unacceptably high need for corticosteroids. However, a validated skin score has not been used to confirm the efficacy of belimumab on m…

medicine.medical_specialtyImmunologyMucocutaneous zoneDiseaseSeverity of Illness IndexDermatomyositislaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicineImmunology and AllergyHumansLupus Erythematosus SystemicRandomized Controlled Trials as TopicSkin030203 arthritis & rheumatologyAutoimmune diseaseWound HealingScleroderma Systemicintegumentary systembusiness.industryDermatomyositismedicine.diseaseDermatologyBelimumabDiscontinuationImmunologybusinessProgressive diseaseImmunosuppressive Agentsmedicine.drugAutoimmunity reviews
researchProduct

Neuropsychological correlates of emotional lability in children with ADHD

2012

Background: Emotional lability (EL) is commonly seen in patients with attention-deficit/hyperactivity disorder (ADHD). The reasons for this association remain currently unknown. To address this question, we examined the relationship between ADHD and EL symptoms, and performance on a range of neuropsychological tasks to clarify whether EL symptoms are predicted by particular cognitive and/or motivational dysfunctions and whether these associations are mediated by the presence of ADHD symptoms. Methods: A large multi-site sample of 424 carefully diagnosed ADHD cases and 564 unaffected siblings and controls aged 618 years performed a broad neuropsychological test battery, including a Go/No-Go …

medicine.medical_specialtyImpulsivitybehavioral disciplines and activities03 medical and health sciences0302 clinical medicinemental disordersSeverity of illnessDevelopmental and Educational PsychologymedicineMemory spanAttention deficit hyperactivity disorder0501 psychology and cognitive sciencesPsychiatrymedicine.diagnostic_test05 social sciencesNeuropsychologyCognitionNeuropsychological testExecutive functionsmedicine.diseasePsychiatry and Mental healthPediatrics Perinatology and Child Healthmedicine.symptomPsychology030217 neurology & neurosurgery050104 developmental & child psychologyJournal of Child Psychology and Psychiatry
researchProduct

Temporal trends in chronic total occlusion interventions in Europe: 17626 procedures from the European Registry of Chronic total occlusion

2018

Background: The study focuses on the evolution of practice, procedural outcomes, and in-hospital complications of chronic total occlusion percutaneous coronary intervention in Europe. Methods and Results: Data from 17 626 procedures enrolled in European Registry of Chronic Total Occlusion between January 2008 and June 2015 were assessed. The mean patient age was 63.9±10.9 years; 85% were men. Procedural success increased from 79.7% to 89.3% through the study period. Patients enrolled during the years had increasing comorbidities and lesion complexity (J-CTO score [Multicenter CTO Registry of Japan] increased from 1.76±1.03 in 2008 to 2.17±0.91 in 2015; P for trend, &lt;0.001). Retrograde a…

medicine.medical_specialtyIn hospital mortalitybusiness.industrymedicine.medical_treatmentPsychological interventionPercutaneous coronary intervention030204 cardiovascular system & hematologyTotal occlusion03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionTreatment OutcomeCoronary OcclusionEmergency medicineChronic DiseaseMedicine030212 general & internal medicineHospital MortalityCardiology and Cardiovascular Medicinebusiness
researchProduct

Clinical Benefits of Early Triptan Therapy for Migraine

2004

The introduction of the triptans brought advances in achieving complete and sustained pain resolution in migraine patients, compared with non-migraine-specific treatments. However, sustained pain-free rates for triptans recorded in many clinical trials are still relatively low. This may be due to study participants being treated late into the attack, when pain is already moderate or severe. Studies with almotriptan have shown that efficacy is enhanced when treatment is given early in a migraine attack while pain is still mild, compared with later administration when pain intensity is greater. Developments in our understanding of migraine pathophysiology provide a rationale for this phenome…

medicine.medical_specialtyIndolesCentral sensitizationMigraine DisordersTriptans03 medical and health sciences0302 clinical medicinePatient satisfactionIntervention (counseling)AlmotriptanSecondary PreventionmedicineHumans030212 general & internal medicinePractice Patterns Physicians'Intensive care medicineAnalgesicsClinical Trials as TopicEvidence-Based Medicinebusiness.industryDisease progressionGeneral Medicinemedicine.diseaseTryptaminesSerotonin Receptor AgonistsClinical trialTreatment OutcomeMigrainePatient SatisfactionAcute DiseaseDisease ProgressionPhysical therapyNeurology (clinical)businessAttitude to Health030217 neurology & neurosurgerymedicine.drugCephalalgia
researchProduct

Immunomodulatory and Hematopoietic Effects of Recombinant Human Interleukin-6 in Patients with Advanced Renal Cell Cancer

1996

Interleukin-6 (IL-6) is a cytokine with pleiotropic biologic activities on B cells, T cells, and hematopoietic progenitors. The present study was undertaken to assess pharmacodynamic effects of subcutaneous administration of IL-6 on blood counts, immunologic parameters, and acute-phase reactants. Blood samples were taken from patients with advanced renal cell cancer participating in a phase II trial of recombinant human IL-6. Multiparameter FACS analyses of peripheral blood mononuclear cells were performed using antibodies against CD3, CD4, CD8, HLA-DR, CD56, CD28, CD38, CD19, sIgM, and sIgG. Serum levels of IL-10, soluble CD23 (sCD23), sCD25, IL-1 receptor antagonist protein (IL-1RA), solu…

medicine.medical_specialtyInjections Subcutaneousmedicine.medical_treatmentImmunologyPeripheral blood mononuclear cellCD19chemistry.chemical_compoundImmunophenotypingAdjuvants ImmunologicVirologyInternal medicinemedicineHumansAcute-Phase ReactionCarcinoma Renal CellbiologyInterleukin-6business.industryCD23NeopterinCell BiologyKidney NeoplasmsRecombinant ProteinsBlood Cell CountHematopoiesisHaematopoiesisCytokineEndocrinologychemistryImmunologybiology.proteinbusinessCD8Journal of Interferon &amp; Cytokine Research
researchProduct

Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury.

2019

Abstract Background Nephrotoxic drug prescription may contribute to acute kidney injury (AKI) occurrence and worsening among critically ill patients and thus to associated morbidity and mortality. The objectives of this study were to describe nephrotoxic drug prescription in a large intensive-care unit cohort and, through a case–control study nested in the prospective cohort, to evaluate the link of nephrotoxic prescription burden with AKI. Results Six hundred and seventeen patients (62%) received at least one nephrotoxic drug, among which 303 (30%) received two or more. AKI was observed in 609 patients (61%). A total of 351 patients were considered as cases developing or worsening AKI a gi…

medicine.medical_specialtyIntensive-care units [MeSH]Critical Care and Intensive Care Medicine[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and NephrologyMESH: Vancomycin03 medical and health sciences0302 clinical medicineMESH: Kidney tubular necrosisRenal insufficiency [MeSH]Internal medicineAnesthesiologyMESH: Renal insufficiencymedicineMESH: Intensive-care unitsKidney tubular necrosisMESH: Diuretics030212 general & internal medicineMedical prescriptionSimplified Acute Physiology ScoreProspective cohort studyMESH: Acutebusiness.industryResearchAcute kidney injurylcsh:Medical emergencies. Critical care. Intensive care. First aidMESH: Aminoglycosides030208 emergency & critical care medicineOdds ratiolcsh:RC86-88.9[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciencesmedicine.diseaseVancomycin [MeSH][SDV.MHEP.UN] Life Sciences [q-bio]/Human health and pathology/Urology and NephrologyDiuretics [MeSH]3. Good health[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciencesContrast media [MeSH]CohortMESH: Contrast mediaAminoglycosides [MeSH]businessAcute [MeSH]Kidney diseaseAnnals of intensive care
researchProduct